A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease—2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we enrolled patients recovered from SARS-CoV-2 infection who had been previously hospitalized for the disease. They were screened for dysphagia by mean of the Eating Assessment Tool-10 (EAT-10). The cases with EAT-10 score > 3 were graded for the aspiration risk by applying the Gugging Swallowing Screen (GUSS) and were submitted to the Swal-QoL questionnaire. The cases with a GUSS score > 19 were subjected to FEES. 8/117 (7%) patients had positive screening result. 4/8 (50%) revealed an abnormal health related quality of life in oropharyngeal dysphagia with a mean Swal-QoL score of 69.73. The most affected domain was the “time of meals” (mean score 65) following by the “sleep” (mean score 66) and “eating desire” (mean score 72). 1/8 cases showed increased risk for aspiration and did not showed endoscopic signs of oropharyngeal dysphagia. Our results showed that the prevalence of upper dysphagia after hospitalization for SARS-CoV-2 is not anecdotal and that probably this long-lasting sequela has a psychogenic etiology.

Marchese, M. R., Ausili Cefaro, C., Mari, G., Proietti, I., Carfi', A., Tosato, M., Longobardi, Y., D'Alatri, L., Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results, <<DYSPHAGIA>>, 2021; 37 (2): 447-453. [doi:10.1007/s00455-021-10325-0] [http://hdl.handle.net/10807/194145]

Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results

Marchese, Maria Raffaella
Primo
;
Ausili Cefaro, Carolina
Secondo
;
Mari, Giorgia;Proietti, Ilaria;Carfi', Angelo;Tosato, Matteo;Longobardi, Ylenia
Penultimo
;
D'Alatri, Lucia
Ultimo
2022

Abstract

A high percentage of patients suffered symptoms also after recovery from the Coronavirus Disease—2019 (COVID-19) infection. It is not well clear what are the specific long-term sequelae (complications and symptoms). During the acute phase the patients may develop a multi-organ system pathology including aerodigestive tract. As the pathophysiology of COVID-19 emerges, the aim of our study was to describe the prevalence of oropharyngeal dysphagia after COVID-19 disease. From March to July 2020 we enrolled patients recovered from SARS-CoV-2 infection who had been previously hospitalized for the disease. They were screened for dysphagia by mean of the Eating Assessment Tool-10 (EAT-10). The cases with EAT-10 score > 3 were graded for the aspiration risk by applying the Gugging Swallowing Screen (GUSS) and were submitted to the Swal-QoL questionnaire. The cases with a GUSS score > 19 were subjected to FEES. 8/117 (7%) patients had positive screening result. 4/8 (50%) revealed an abnormal health related quality of life in oropharyngeal dysphagia with a mean Swal-QoL score of 69.73. The most affected domain was the “time of meals” (mean score 65) following by the “sleep” (mean score 66) and “eating desire” (mean score 72). 1/8 cases showed increased risk for aspiration and did not showed endoscopic signs of oropharyngeal dysphagia. Our results showed that the prevalence of upper dysphagia after hospitalization for SARS-CoV-2 is not anecdotal and that probably this long-lasting sequela has a psychogenic etiology.
2022
Inglese
Marchese, M. R., Ausili Cefaro, C., Mari, G., Proietti, I., Carfi', A., Tosato, M., Longobardi, Y., D'Alatri, L., Oropharyngeal Dysphagia After Hospitalization for COVID-19 Disease: Our Screening Results, <<DYSPHAGIA>>, 2021; 37 (2): 447-453. [doi:10.1007/s00455-021-10325-0] [http://hdl.handle.net/10807/194145]
File in questo prodotto:
File Dimensione Formato  
Oropharyngeal Dysphagia After Hospitalization for COVID‑19 Disease.pdf

accesso aperto

Licenza: Creative commons
Dimensione 565.6 kB
Formato Adobe PDF
565.6 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/194145
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 11
social impact